跳转至内容
Merck
CN

HLA002

Jurkat HLA Panel Cell Lines

别名:

Immuno-oncology, CAR-T, Checkpoint Inhibitors, Immunotherapy, Oncology

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

UNSPSC Code:
41106514
Biological source:
human (T Lymphocyte (blood))
Growth mode:
suspension
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

human (T Lymphocyte (blood))

growth mode

suspension

shipped in

dry ice

storage temp.

−196°C

General description

The STR profile of these cell lines match that of its parental cell line - ECACC catalog number 88042803.

This product is a panel of eleven (11) genetically modified cell lines targeting MHC Class I HLA molecules in a Jurkat T lymphocyte parental cell line background.  The full HLA panel consists of a Beta-2 microglobulin (β2M) knockout cell line and an additional ten (10) monoallelic HLA expression cell lines.  

CompoZr® Zinc Finger Nuclease (ZFN) technology was used to generate the β2M knockout cell line, which does not express endogenous cell surface MHC Class I HLA molecules (HLA-A or HLA-B) as measured by fluorescence-activated cell sorting (FACS).  

MISSION® lentivirus was used to generate the ten (10)  monoallelic HLA cell lines, which express individual HLA-A or HLA-B subtypes on the cell surface via a β2M:HLA fusion protein as described in Nature Biotechnology 35, 765-772, (2017) and as demonstrated via FACS analysis.  

Biochem/physiol Actions

Derived from Jurkat FHCRC. An IL-2 producing cell line, derived by incubating the cells at 41°C for 48 hours followed by a limiting dilution cloning over macrophages.

Features and Benefits

Unlike wild type Jurkat cells, which express multiple HLA subtypes, the Jurkat HLA panel cell lines express individual MHC Class I HLA subtypes. These monoallelic HLA cell lines can be used to study peptide binding and presentation in the context of individual HLA subtypes. The panel can also be used to develop cell-based assays to evaluate candidate cancer immunotherapies and identify tumor-specific neoantigens.

Analysis Note

Tested for Mycoplasma, bacterial and fungal content, post-freeze viability, and short terminal repeat (STR) analysis for cell line identification.

Other Notes

HLA002A-1VL: Jurkat B2M KO Cells
HLA002B-1VL: Jurkat HLA-A*02:01 Cells
HLA002C-1VL: Jurkat HLA-A*01:01 Cells
HLA002D-1VL: Jurkat HLA-A*03:01 Cells
HLA002E-1VL: Jurkat HLA-A*11:01 Cells
HLA002F-1VL: Jurkat HLA-A*24:02 Cells
HLA002G-1VL: Jurkat HLA-B*15:10 Cells
HLA002H-1VL: Jurkat HLA-B*07:02 Cells
HLA002I-1VL: Jurkat HLA-B*08:01 Cells
HLA002J-1VL: Jurkat HLA-B*35:01 Cells
HLA002K-1VL: Jurkat HLA-B*40:01 Cells

Legal Information

CompoZr is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

This product is regulated in France when intended for scientific purposes, including import, export, and conservation activities (Articles L.1211-1, paragraph 2, and L.1243-4 of the French Public Health Code). The purchaser (i.e. end user) is required to obtain an import authorization from the France Ministry responsible for Research (as referenced in Article L.1245-5-1 II of the French Public Health Code) or a conservation authorization from the same ministry (as referenced in Article L.1243-4 of the French Public Health Code). By placing an order for this product, you confirm that you have obtained the appropriate import or conservation authorization for the product. For more information regarding the use of human biological samples for research purposes in France, please contact the relevant French authorities.


存储类别

10 - Combustible liquids



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库